Opportunities for Integrated Control of Neglected Tropical Diseases That Affect the Skin

Trends in Parasitology

Volumn 32, Issue 11, 2016, Pages 843-854

  Engelman, Daniel ^a,b   Fuller, L Claire ^c,d   Solomon, Anthony W ^e   McCarthy, James S ^f   Hay, Roderick J ^d,g   Lammie, Patrick J ^h   Steer, Andrew C ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^d International Foundation for Dermatology   (United Kingdom)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

mass drug administration; neglected tropical disease; scabies; skin disease; yaws

Indexed keywords

IVERMECTIN; ANTIINFECTIVE AGENT;

CLINICAL EXAMINATION; DISABILITY; FUNDING; GROUP THERAPY; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTEGRATED HEALTH CARE SYSTEM; NEGLECTED DISEASE; PREVENTIVE HEALTH SERVICE; REVIEW; SKIN EXAMINATION; SKIN INFECTION; TROPICAL DISEASE; WORLD HEALTH ORGANIZATION; HEALTH CARE DELIVERY; NEGLECTED DISEASES; PARASITOLOGY; SKIN DISEASES; STANDARDS; TRENDS; TROPICAL MEDICINE;

ANTI-INFECTIVE AGENTS; DELIVERY OF HEALTH CARE; HUMANS; NEGLECTED DISEASES; SKIN DISEASES; TROPICAL MEDICINE;

EID: 84994106618     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2016.08.005     Document Type: Review

References (86)

1. 1 World Health Organization, Working to Overcome the Global Impact of Neglected Tropical Diseases: First WHO Report on Neglected Tropical Diseases., 2010, World Health Organization.
2. 2 Hotez, P., et al. The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination. Adv. Exp. Med. Biol. 582 (2006), 23–33.
3. 3 Hofstraat, K., van Brakel, W.H., Social stigma towards neglected tropical diseases: a systematic review. Int. Health 8 (2016), i53–i70.
4. 4 Kabatereine, N.B., et al. How to (or not to) integrate vertical programmes for the control of major neglected tropical diseases in sub-Saharan Africa. PLoS Negl. Trop. Dis., 4, 2010, e755.
5. 5 World Health Organization Western Pacific Region, Regional Action Plan for Neglected Tropical Diseases in the Western Pacific (2012-2016). 2013, World Health Organization.
6. 6 Hotez, P., A new voice for the poor. PLoS Negl. Trop. Dis., 1, 2007, e77.
7. 7 Zijlstra, E.E., et al. Mycetoma: a long journey from neglect. PLoS Negl. Trop. Dis., 10, 2016, e0004244.
8. 8 Hengge, U.R., et al. Scabies: a ubiquitous neglected skin disease. Lancet Infect. Dis. 6 (2006), 769–779.
9. 9 Deribe, K., et al. The feasibility of eliminating podoconiosis. Bull. World Health Organ. 93 (2015), 712–718.
10. 10 Davey, G., Newport, M., Podoconiosis: the most neglected tropical disease?. Lancet 369 (2007), 888–889.
11. 11 Hay, R.J., et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J. Invest. Dermatol. 134 (2014), 1527–1534.
12. 12 Clucas, D.B., et al. Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. Bull. World Health Organ. 86 (2008), 275–281.
13. 13 Figueroa, J.I., et al. Dermatology in southwestern Ethiopia: rationale for a community approach. Int. J. Dermatol. 37 (1998), 752–758.
14. 14 Figueroa, J.I., et al. The prevalence of skin disease among school children in rural Ethiopia – a preliminary assessment of dermatologic needs. Pediatr. Dermatol. 13 (1996), 378–381.
15. 15 Tasani, M., et al. The importance of scabies coinfection in the treatment considerations for impetigo. Pediatr. Infect. Dis. J. 35 (2016), 374–378.
16. 16 Romani, L., et al. Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect. Dis. 15 (2015), 960–967.
17. 17 Swe, P.M., et al. Parasitic scabies mites and associated bacteria joining forces against host complement defence. Parasite Immunol. 36 (2014), 585–593.
18. 18 Engelman, D., et al. Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl. Trop. Dis., 7, 2013, e2167.
19. 19 Bonifaz, A., et al. Tinea imbricata or Tokelau. Int. J. Dermatol. 43 (2004), 506–510.
20. 20 Hay, R.J., et al. The global challenge for skin health. Br. J. Dermatol. 172 (2015), 1469–1472.
21. 21 Solomon, A.W., et al. The Global Trachoma Mapping Project: methodology of a 34-country population-based study. Ophthalmic Epidemiol. 22 (2015), 214–225.
22. 22 Marks, M., et al. Mapping the epidemiology of yaws in the Solomon Islands: a cluster randomized survey. Am. J. Trop. Med. Hyg. 92 (2015), 129–133.
23. 23 Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement. Wkly. Epidemiol. Rec. 87 (2012), 478–482.
24. 24 Sime, H., et al. Integrated mapping of lymphatic filariasis and podoconiosis: lessons learnt from Ethiopia. Parasit. Vectors, 7, 2014, 397.
25. 25 World Health Organization, Sustaining the Drive To Overcome the GLOBAL Impact of Neglected Tropical Diseases: Second WHO Report on Neglected Tropical Diseases., 2013, World Health Organization.
26. 26 Cooley, G.M., et al. Evaluation of multiplex-based antibody testing for use in large-scale surveillance for yaws: a comparative study. J. Clin. Microbiol. 54 (2016), 1321–1325.
27. 27 Priest, J.W., et al. Integration of multiplex bead assays for parasitic diseases into a national, population-based serosurvey of women 15-39 years of age in Cambodia. PLoS Negl. Trop. Dis., 10, 2016, e0004699.
28. 28 Notomi, T., et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res., 28, 2000, E63.
29. 29 Mofiz, E., et al. Genomic resources and draft assemblies of the human and porcine varieties of scabies mites. Sarcoptes scabiei var. hominis and var. suis. GigaScience, 5, 2016, 23.
30. 30 Steer, A.C., et al. Validation of an Integrated Management of Childhood Illness algorithm for managing common skin conditions in Fiji. Bull. World Health Organ. 87 (2009), 173–179.
31. 31 Faye, O., et al. A public health approach for leprosy detection based on a very short term-training of primary health care workers in basic dermatology. Lepr. Rev. 78 (2007), 11–16.
32. 32 Mahe, A., et al. Definition of an algorithm for the management of common skin diseases at primary health care level in sub-Saharan Africa. Trans. R. Soc. Trop. Med. Hyg. 99 (2005), 39–47.
33. 33 Hay, R., et al. Managing skin disease in resource-poor environments – the role of community-oriented training and control programs. Int. J. Dermatol. 50 (2011), 558–563.
34. 34 Mahe, A., et al. Integration of basic dermatological care into primary health care services in Mali. Bull. World Health Organ. 83 (2005), 935–941.
35. 35 Estrada, R., et al. Specialized dermatological care for marginalized populations and education at the primary care level: is community dermatology a feasible proposal?. Int. J. Dermatol. 51 (2012), 1345–1350.
36. 36 Noormahomed, E.V., et al. Onchocerciasis, an undiagnosed disease in Mozambique: identifying research opportunities. Parasit. Vectors, 9, 2016, 180.
37. 37 Hotez, P.J., Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin. Pharmacol. Ther. 85 (2009), 659–664.
38. 38 World Health Organization, Eradication of yaws – the Morges strategy. Wkly. Epidemiol. Rec. 87 (2012), 189–194.
39. 39 Linehan, M., et al. Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: proving the feasibility at national scale. Am. J. Trop. Med. Hyg. 84 (2011), 5–14.
40. 40 Mengitsu, B., et al. Ethiopia and its steps to mobilize resources to achieve 2020 elimination and control goals for neglected tropical diseases webs joined can tie a lion. Int. Health 8:Suppl 1 (2016), i34–i52.
41. 41 Hotez, P.J., et al. Control of neglected tropical diseases. N. Eng. J. Med. 357 (2007), 1018–1027.
42. 42 Ottesen, E.A., et al. The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl. Trop. Dis., 2, 2008, e317.
43. 43 Molyneux, D.H., Ward, S.A., Reflections on the Nobel Prize for Medicine 2015 – the public health legacy and impact of avermectin and artemisinin. Trends Parasitol. 31 (2015), 605–607.
44. 44 Omura, S., Crump, A., Ivermectin: panacea for resource-poor communities?. Trends Parasitol. 30 (2014), 445–455.
45. 45 Heukelbach, J., et al. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull. World Health Organ. 82 (2004), 563–571.
46. 46 Krotneva, S.P., et al. African Program for Onchocerciasis Control 1995-2010: impact of annual ivermectin mass treatment on off-target infectious diseases. PLoS Negl. Trop. Dis., 9, 2015, e0004051.
47. 47 Mohammed, K.A., et al. Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis – a rapid assessment methodology to assess impact. Parasit. Vectors, 5, 2012, 299.
48. 48 Ndyomugyenyi, R., et al. Perceptions on onchocerciasis and ivermectin treatment in rural communities in Uganda: implications for long-term compliance. Int. Health 1 (2009), 163–168.
49. 49 Thomsen, E.K., et al. Efficacy, safety, and pharmacokinetics of coadministered diethylcarbamazine, albendazole, and ivermectin for treatment of bancroftian filariasis. Clin. Infect. Dis. 62 (2016), 334–341.
50. 50 Kastner, R.J., et al. What is needed to eradicate lymphatic filariasis?. A model-based assessment on the impact of scaling up mass drug administration programs. PLoS Negl. Trop. Dis., 9, 2015, e0004147.
51. 51 Hotez, P.J., et al. Integrating neglected tropical diseases into AIDS, tuberculosis, and malaria control. N. Eng. J. Med. 364 (2011), 2086–2089.
52. 52 WHO Malaria Policy Advisory Committee Secretariat, Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015). Malar. J., 15, 2016, 117.
53. 53 Solomon, A.W., et al. Trachoma and yaws: common ground?. PLoS Negl. Trop. Dis., 9, 2015, e0004071.
54. 54 Marks, M., et al. Impact of community mass treatment with azithromycin for trachoma elimination on the prevalence of yaws. PLoS Negl. Trop. Dis., 9, 2015, e0003988.
55. 55 Coulibaly, Y.I., et al. A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali. PLoS Negl. Trop. Dis., 7, 2013, e2221.
56. 56 Mohammed, K.A., et al. Triple co-administration of ivermectin, albendazole and praziquantel in Zanzibar: a safety study. PLoS Negl. Trop. Dis., 2, 2008, e171.
57. 57 Currie, B.J., et al. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin. Infect. Dis. 39 (2004), e8–e12.
58. 58 Coles, C.L., et al. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment. Clin. Infect. Dis. 56 (2013), 1519–1526.
59. 59 Ho, D.K., et al. Antibiotic resistance in Streptococcus pneumoniae after azithromycin distribution for trachoma. J. Trop. Med., 2015, 2015, 917370.
60. 60 Gagliotti, C., et al. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes. Clin. Infect. Dis. 42 (2006), 1153–1156.
61. 61 Batt, S.L., et al. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47 (2003), 2765–2769.
62. 62 Sikorski, C., et al. Effectiveness of a simple lymphoedema treatment regimen in podoconiosis management in southern Ethiopia: one year follow-up. PLoS Negl. Trop. Dis., 4, 2010, e902.
63. 63 Negussie, H., et al. Podoconiosis treatment in northern Ethiopia (GoLBet): study protocol for a randomised controlled trial. Trials, 16, 2015, 307.
64. 64 Jullien, P., et al. Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso. Acta Trop. 120:Suppl. 1 (2011), S55–S61.
65. 65 van ‘t Noordende, A.T., et al. Towards a toolkit for cross-neglected tropical disease morbidity and disability assessment. Int. Health 8 (2016), i71–i81.
66. 66 Boisson, S., et al. Water, sanitation and hygiene for accelerating and sustaining progress on neglected tropical diseases: a new global strategy 2015-20. Int. Health 8 (2016), i19–i21.
67. 67 Freeman, M.C., et al. Integration of water, sanitation, and hygiene for the prevention and control of neglected tropical diseases: a rationale for inter-sectoral collaboration. PLoS Negl. Trop. Dis., 7, 2013, e2439.
68. 68 Johnston, E.A., et al. Challenges and opportunities associated with neglected tropical disease and water, sanitation and hygiene intersectoral integration programs. BMC Public Health, 15, 2015, 547.
69. 69 Leslie, J., et al. Neglected tropical diseases: comparison of the costs of integrated and vertical preventive chemotherapy treatment in Niger. Int. Health 5 (2013), 78–84.
70. 70 Evans, D., et al. Cost-effectiveness of triple drug administration (TDA) with praziquantel, ivermectin and albendazole for the prevention of neglected tropical diseases in Nigeria. Ann. Trop. Med. Parasitol. 105 (2011), 537–547.
71. 71 Brady, M.A., et al. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol. 22 (2006), 285–291.
72. 72 Lammie, P.J., et al. A blueprint for success: integration of neglected tropical disease control programmes. Trends Parasitol. 22 (2006), 313–321.
73. 73 Smith, J., Taylor, E.M., What is next for NTDs in the era of the sustainable development goals?. PLoS Negl. Trop. Dis., 10, 2016, e0004719.
74. 74 Holmes, P., Neglected tropical diseases in the post-2015 health agenda. Lancet, 383, 2014, 1803.
75. 75 World Health Organization, Investing to Overcome the Global Impact of Neglected Tropical Diseases: Third WHO Report on Neglected Tropical Diseases., 2015, World Health Organization.
76. 76 Hay, R.J., et al. Scabies in the developing world – its prevalence, complications, and management. Clin. Microbiol. Infect. 18 (2012), 313–323.
77. 77 La Vincente, S., et al. Community management of endemic scabies in remote aboriginal communities of northern Australia: low treatment uptake and high ongoing acquisition. PLoS Negl. Trop. Dis., 3, 2009, e444.
78. 78 Romani, L., et al. Mass drug administration for scabies control in a population with endemic disease. N. Eng. J. Med. 373 (2015), 2305–2313.
79. 79 Lawrence, G., et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull. World Health Organ. 83 (2005), 34–42.
80. 80 Kearns, T.M., et al. Impact of an ivermectin mass drug administration on scabies prevalence in a remote australian aboriginal community. PLoS Negl. Trop. Dis., 9, 2015, e0004151.
81. 81 Mason, D.S., et al. The prevalence of scabies and impetigo in the Solomon Islands: a population-based survey. PLoS Negl. Trop. Dis., 10, 2016, e0004803.
82. 82 Mounsey, K.E., et al. Prospects for moxidectin as a new oral treatment for human scabies. PLoS Negl. Trop. Dis., 10, 2016, e0004389.
83. 83 Al-Awadi, A.R., et al. Guinea worm (Dracunculiasis) eradication: update on progress and endgame challenges. Trans. R. Soc. Trop. Med. Hyg. 108 (2014), 249–251.
84. 84 Hotez, P.J., et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl. Trop. Dis., 8, 2014, e2865.
85. 85 Molyneux, D.H., Tropical lymphedemas – control and prevention. N. Engl. J. Med. 366 (2012), 1169–1171.
86. 86 Bethony, J., et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367 (2006), 1521–1532.